Increased plasma levels of high mobility group box 1 protein in patients with bipolar disorder: A pilot study

被引：5
|
作者：
Marie-Claire, Cynthia [1 ]
Courtin, Cindie [1 ]
Curis, Emmanuel [1 ,2 ,3 ]
Bouaziz-Amar, Elodie [1 ,4 ]
Laplanche, Jean-Louis [1 ,4 ]
Jacob, Aude [1 ]
Etain, Bruno [1 ,5 ,6 ]
Blanchard, Anne [7 ]
Bellivier, Frank [1 ,5 ,6 ]
机构：
[1] Univ Paris Diderot, Univ Sorbonne Paris Cite, Univ Paris Descartes, INSERM Optimisat Therapeut Neuropsychopharmacol U, Paris, France
[2] GH St Louis Lariboisiere F Widal, AP HP, Dept Biostat & Informat Med, Paris, France
[3] Univ Paris 05, Fac Pharm Paris, Lab Biomath, Plateau iB2,EA 7537 BioSTM, F-75006 Paris, France
[4] GH St Louis Lariboisiere F Widal, Dept Biochim & Biol Mol, Paris, France
[5] GH St Louis Lariboisiere F Widal, AP HP, Pole Psychiat & Med Addictol, F-75475 Paris 10, France
[6] Fondat Fondamental, Creteil, France
[7] Univ Paris 05, Hop Europeen Georges Pompidou, AP HP, INSERM CIC1418, F-75015 Paris, France
来源：
JOURNAL OF NEUROIMMUNOLOGY | 2019年 / 334卷
关键词：
HMGB1; Bipolar disorder; Plasma; Inflammation; C-REACTIVE PROTEIN; HMGB1; CELLS; ASSOCIATION; CYTOKINES; ABUNDANCE; BIOMARKER; STRESS;
D O I：
10.1016/j.jneuroim.2019.576993
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
High mobility group box 1 (HMGB1) is a pro-inflammatory cytokine that emerges as a promising peripheral marker of inflammation. HMGB1 and C-reactive protein levels were assessed in plasma of control subjects and remitted patients with bipolar disorder (BD). HMGB1 levels were significantly higher in patients with BD as compared to control subjects whereas C-reactive protein levels did not differ between the two groups. No significant effect of potential covariates was identified. The results of this pilot study suggest that HMGB1 might be a specific peripheral marker of inflammation in BD.
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Increased serum levels of high mobility group box 1 protein in patients with autistic disorder
    Emanuele, Enzo
    Boso, Marianna
    Brondino, Natascia
    Pietra, Stefania
    Barale, Francesco
    di Nemi, Stefania Ucelli
    Politi, Pierluigi
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (04) : 681 - 683
  • [2] High Mobility Group Box 1 Levels as an Inflammatory Mediator in Bipolar Mania
    Kara, Aysu
    Balaban, Ozlem Devrim
    Cinar, Bilge
    Olug, Seda Tanriverdi
    Kilic, Cenk
    Karamustafalioglu, Nesrin
    NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, 2024, 61 (02): : 160 - 166
  • [3] May high mobility group box protein-1 be a biomarker for major depressive disorder?
    Kose, Ali Emre
    Turan, Tayfun
    Kilic, Eser
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 396
  • [4] Plasma levels of high mobility group box 1 increase in patients with posttraumatic stress disorder after severe blunt chest trauma: a prospective cohort study
    Wang, Xiao-Wen
    Karki, Avash
    Du, Ding-Yuan
    Zhao, Xing-Ji
    Xiang, Xiao-Yong
    Lu, Zhi-Qian
    JOURNAL OF SURGICAL RESEARCH, 2015, 193 (01) : 308 - 315
  • [5] Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder
    Izabela Guimarães Barbosa
    Rodrigo Barreto Huguet
    Vanessa Amaral Mendonça
    Lirlândia Pires Sousa
    Fernando Silva Neves
    Moisés Evandro Bauer
    Antônio Lúcio Teixeira
    European Archives of Psychiatry and Clinical Neuroscience, 2011, 261 : 139 - 143
  • [6] Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder
    Barbosa, Izabela Guimaraes
    Huguet, Rodrigo Barreto
    Mendonca, Vanessa Amaral
    Sousa, Lirlandia Pires
    Neves, Fernando Silva
    Bauer, Moises Evandro
    Teixeira, Antonio Lucio
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2011, 261 (02) : 139 - 143
  • [7] High mobility group box chromosomal protein 1 in patients with renal diseases
    Sato, Fumihiko
    Maruyama, Shoichi
    Hayashi, Hiroki
    Sakamoto, Izumi
    Yamada, Shingo
    Uchimura, Tomonori
    Morita, Yoshiki
    Ito, Yasuhiko
    Yuzawa, Yukio
    Maruyama, Ikuro
    Matsuo, Seiichi
    NEPHRON CLINICAL PRACTICE, 2008, 108 (03): : C194 - C201
  • [8] Association of high mobility group box-1 protein levels with sepsis and outcome of severely burned patients
    Huang, Li-feng
    Yao, Yong-ming
    Dong, Ning
    Yu, Yan
    He, Li-xin
    Sheng, Zhi-yong
    CYTOKINE, 2011, 53 (01) : 29 - 34
  • [9] Faecal high mobility group box 1 in children with celiac disease: A pilot study
    Palone, Francesca
    Vitali, Roberta
    Trovato, Chiara Maria
    Montuori, Monica
    Negroni, Anna
    Mallardo, Saverio
    Stronati, Laura
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (09) : 916 - 919
  • [10] Plasma Levels of High-Mobility Group Box 1 during Peptide Vaccination in Patients with Recurrent Ovarian Cancer
    Waki, Kayoko
    Kawano, Kouichiro
    Tsuda, Naotake
    Ushijima, Kimio
    Itoh, Kyogo
    Yamada, Akira
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
12345